U.S. Markets closed

Endo Shares Move Higher On Settlement Of New York State Opioid Cases

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • ENDP
  • Endo International plc (NASDAQ: ENDP) has agreed to pay million to resolve lawsuits by New York state and two of its largest counties related to the sale and marketing of opioids.

  • Endo said the settlement includes no admission of wrongdoing by Endo or its subsidiaries.

  • The settlement severs Endo from an ongoing trial in lawsuits by New York Attorney General Letitia James and Suffolk and Nassau counties.

  • The deal came after McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH), and Johnson & Johnson (NYSE: JNJ) said they would move forward with a proposed $26 billion settlement resolving opioid cases against them.

  • Related Content: Opioid Settlement Of B Between Drug Companies, States.

  • In July, Endo agreed to pay million to settle a lawsuit by Tennessee local governments.

  • Last month, Wall Street Journal reported that Endo engaged Alvarez & Marsal to look into a potential financial restructuring.

  • Price Action: ENDP stock is up 15.20% at $2.42 during the premarket session on the last check Friday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.